Description

Retatrutide 10 mg (HBW-RT) – Multi-Receptor Target Reference Material

Retatrutide is a potent triple-agonist targeting the GIP, GLP-1, and glucagon receptors, supplied as a formulated reference material for advanced preclinical research. It is primarily studied for its multi-pathway effects on metabolic signaling, energy expenditure, glucose metabolism regulation, and lipid homeostatic mechanisms.

Research-Only Use This material is strictly intended for laboratory research and analytical evaluation only. It is not intended for human consumption, clinical application, or veterinary use. No assertions are made regarding its safety, clinical performance, or therapeutic potential.

Disclaimer The information provided is intended exclusively for scientific and educational context and should not be construed as medical advice or an intent to diagnose, treat, cure, or prevent any illness. This product has not been cleared or evaluated by any regulatory body.

Terms of Sale By purchasing this material, you affirm that you represent a certified laboratory, research institution, or qualified researcher complying with all applicable regional and federal guidelines. The seller disclaims all liability for unauthorized use, improper storage, unlawful resale, or personal harm, with all associated risks transferred to the buyer.